Patents by Inventor Emma L. Blaney

Emma L. Blaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMPOUNDS
    Publication number: 20220002286
    Abstract: The present invention relates to compounds that are Nrf2 activators. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.
    Type: Application
    Filed: October 22, 2019
    Publication date: January 6, 2022
    Inventors: Emma L. Blaney, Duncan J. Crick, Simon R. Crumpler, George Hynd, Cathy L. Lucas, Barrie P. Martin, Nick C. Ray, Eileen M. Seward, David G. Evans, Lucille Le Bozec, Thorsten Nowak, Michael G. Russell, Siew K. Yeap, Fabien J. Roussel, Sanjeet S. Sehmi
  • CARBAZOLE AND CARBOLINE DERIVATIVES, AND PREPARATION AND THERAPEUTIC APPLICATIONS THEREOF
    Publication number: 20130274258
    Abstract: Compounds of general formula (I), wherein A, Y, R1 and R2 are defined herein are useful in the treatment or prevention of proliferative diseases including cancer or infectious or parasitic diseases.
    Type: Application
    Filed: November 3, 2011
    Publication date: October 17, 2013
    Applicant: PHILIP MORRIS PRODUCTS S.A.
    Inventors: Stephane Demotz, Gerhard Lang, Damian McHugh, Axel Teichert, Fernando Goffman, Paul M. Doyle, Paul M. Blaney, Raymond Fisher, Andrew Smith, Emma L. Blaney, Simon Foster